Merck Neuroscience Acquisition Brings a Startup With Parkinson's, ALS Programs

Retrieved on: 2023-11-21 18:17:10

Tags for this article:

Click the tags to see associated articles and topics

Merck Neuroscience Acquisition Brings a Startup With Parkinson's, ALS Programs. View article details on hiswai:

Excerpt

Merck is shoring up its neuroscience pipeline with the acquisition of Caraway Therapeutics, a preclinical startup with programs in Parkinson's ...

Article found on: medcitynews.com